iHealthScreen, an artificial intelligence (“AI”)-based health-screening company, has scheduled an exclusive Q&A webinar. CEO Alauddin Bhuiyan will host the event, which is slated for July 11, 2023, at 9 a.m. PDT. During the webinar, Bhuiyan will provide an overview of the company, including how iHealthScreen is disrupting the billion-dollar health screening market; he will also discuss the unique benefits of iHealthScreen’s investment opportunity, which capitalizes on the company’s proprietary AI-driven, health-screening software. According to the announcement, iHealthScreen is one of the first companies in the world to receive CE certification and Australian and UAE health approvals for the screening of age-related macular degeneration (“AMD”), diabetic retinopathy (“DR”) and glaucoma.
To attend the webinar, visit https://ibn.fm/4ZkRd
To view the full press release, visit https://ibn.fm/nrGqO
About iHealthScreen
iHealthScreen’s integrated, retinal imaging-based system makes it one of the first companies in the world to receive CE certification, Australian and UAE health approvals for AMD, DR and glaucoma screening. The company is gaining international traction with contracts in the United States, European Union, Bangladesh and UAE; the company has also been collaborating with Global Victoria in Australia. For more information, please visit www.StartEngine.com/offering/iHealthScreen.
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork